Key facts
- This page summarizes Jeffrey Scott Kitchell's Form 3 filing for PURE BIOSCIENCE, INC. (PURE).
- 0 reported transactions and 7 derivative rows are listed below.
- Accepted by SEC: 28 Nov 2025, 18:25.
Jeffrey Scott Kitchell - 17 Nov 2025 Form 3 Insider Report for PURE BIOSCIENCE, INC. (PURE)
- Reporting relationship
- President, Corporate Secretary
- Issuer ticker
- PURE
- Reported as of
- 17 Nov 2025
- Net transaction value
- $0
- Reporting owner signature
- /s/ Jeffrey Scott Kitchell
Source evidence
Original filing metadata and source links for verification.
3 source fields
Reporting owner
1 detail
Key filing fact
Jeffrey Scott Kitchell filed Form 3 for PURE BIOSCIENCE, INC. (PURE) on 28 Nov 2025.
Change
- No earlier filing in this sequence is available for direct comparison.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Official SEC source
View source filing
Ownership activity is grounded in SEC Form 3 disclosures.
Reporting Owners (1)
CIK 0002098340
Primary reporting owner
Kitchell Jeffrey Scott
- Relationship
- President, Corporate Secretary
- Address
- 771 JAMACHA RD., #512, EL CAJON
- Signature
- /s/ Jeffrey Scott Kitchell
- Signature date
- 28 Nov 2025
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
PURE
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 12,998
- Date
- 17 Nov 2025
- Ownership
- Direct
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
PURE
holding
Derivative
Stock Options (Right to Buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 17 Nov 2025
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 45,000
- Exercise price
- $0.3300
- Footnotes
- F1
PURE
holding
Derivative
Stock Options (Right to Buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 17 Nov 2025
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 45,000
- Exercise price
- $0.7900
- Footnotes
- F2
PURE
holding
Derivative
Stock Options (Right to Buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 17 Nov 2025
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 70,000
- Exercise price
- $0.4500
- Footnotes
- F3
PURE
holding
Derivative
Stock Options (Right to Buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 17 Nov 2025
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 90,000
- Exercise price
- $0.2000
- Footnotes
- F4
PURE
holding
Derivative
Stock Options (Right to Buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 17 Nov 2025
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 150,000
- Exercise price
- $0.1200
- Footnotes
- F5
PURE
holding
Derivative
Stock Options (Right to Buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 17 Nov 2025
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 155,000
- Exercise price
- $0.0700
- Footnotes
- F6
PURE
holding
Derivative
Stock Options (Right to Buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 17 Nov 2025
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 300,000
- Exercise price
- $0.0740
- Footnotes
- F7
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 7 footnotes
Footnote F1
The option was granted on January 29, 2020 and became fully vested on January 29, 2021.
Footnote F2
The option was granted on May 15, 2020 and became fully vested on May 15, 2021.
Footnote F3
The option was granted on June 18, 2021 and became fully vested on June 18, 2022.
Footnote F4
The option was granted on September 30, 2022 and became fully vested on September 30, 2023.
Footnote F5
The option was granted on August 1, 2023 and became fully vested on August 1, 2024.
Footnote F6
The option was granted on August 20, 2024 and became fully vested on August 20, 2025.
Footnote F7
The option was granted on September 23, 2025. The option shares shall vest and become exercisable in four equal installments on December 23, 2025, March 23, 2026, June 23, 2026, and September 23, 2026.